ATE492638T1 - Vektorkonstruktionen - Google Patents

Vektorkonstruktionen

Info

Publication number
ATE492638T1
ATE492638T1 AT07000056T AT07000056T ATE492638T1 AT E492638 T1 ATE492638 T1 AT E492638T1 AT 07000056 T AT07000056 T AT 07000056T AT 07000056 T AT07000056 T AT 07000056T AT E492638 T1 ATE492638 T1 AT E492638T1
Authority
AT
Austria
Prior art keywords
vector constructions
expression
double
stranded rna
vector
Prior art date
Application number
AT07000056T
Other languages
English (en)
Inventor
Geert Plaetinck
Jean-Pierre Renard
Thierry Bogaert
Original Assignee
Devgen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9891999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE492638(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Devgen Nv filed Critical Devgen Nv
Application granted granted Critical
Publication of ATE492638T1 publication Critical patent/ATE492638T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Optical Communication System (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Control Of Ac Motors In General (AREA)
  • Soft Magnetic Materials (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07000056T 2000-05-19 2001-05-18 Vektorkonstruktionen ATE492638T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012233.3A GB0012233D0 (en) 2000-05-19 2000-05-19 Vector constructs

Publications (1)

Publication Number Publication Date
ATE492638T1 true ATE492638T1 (de) 2011-01-15

Family

ID=9891999

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07000056T ATE492638T1 (de) 2000-05-19 2001-05-18 Vektorkonstruktionen
AT01938492T ATE354652T1 (de) 2000-05-19 2001-05-18 Vektorkonstrukte

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01938492T ATE354652T1 (de) 2000-05-19 2001-05-18 Vektorkonstrukte

Country Status (9)

Country Link
US (2) US7358069B2 (de)
EP (2) EP1775345B1 (de)
JP (2) JP5153983B2 (de)
AT (2) ATE492638T1 (de)
AU (1) AU2001264166A1 (de)
DE (2) DE60126760T2 (de)
ES (2) ES2281420T3 (de)
GB (2) GB0012233D0 (de)
WO (1) WO2001088121A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs
US7612194B2 (en) * 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
US20040180438A1 (en) 2002-04-26 2004-09-16 Pachuk Catherine J. Methods and compositions for silencing genes without inducing toxicity
AU2003239851A1 (en) * 2002-05-08 2003-11-11 Xantos Biomedicine Ag Expression constructs for producing double-stranded (ds) rna and the use thereof
US7399586B2 (en) 2002-05-23 2008-07-15 Ceptyr, Inc. Modulation of biological signal transduction by RNA interference
JP4563171B2 (ja) * 2002-05-24 2010-10-13 シェーリング コーポレイション 中和ヒト抗ｉｇｆｒ抗体
US20100009856A1 (en) * 2002-06-21 2010-01-14 Sinogenomax Sompany LTD. Randomized dna libraries and double-stranded rna libraries, use and method of production thereof
US20050196862A1 (en) * 2002-08-30 2005-09-08 Wooddell Christine I. DNA cassette for cellular expression of small RNA
CN1938428A (zh) 2003-11-12 2007-03-28 先灵公司 多基因表达的质粒系统
TW200526684A (en) 2003-11-21 2005-08-16 Schering Corp Anti-IGFR1 antibody therapeutic combinations
EP2402441A1 (de) 2004-04-09 2012-01-04 Monsanto Technology, LLC Zusammensetzungen und Verfahren zur Kontrolle von Insektenbefall bei Pflanzen
CA2940718C (en) 2004-09-24 2019-06-18 J.R. Simplot Company Gene silencing
CA2584960A1 (en) 2004-10-21 2006-05-04 Charles L. Niblett Methods and materials for conferring resistance to pests and pathogens of plants
PL1807520T3 (pl) 2004-10-25 2013-01-31 Devgen Nv Konstrukty do RNA
US20060242736A1 (en) 2004-12-23 2006-10-26 Shihshieh Huang Dissimilar promoters for gene suppression
EP2500429A3 (de) 2005-05-31 2015-10-28 Devgen N.V. RNAi zur Kontrolle von Insekten und Spinnen
HUE031692T2 (en) 2005-09-16 2017-07-28 Monsanto Technology Llc Procedures for genetic control of insect infestations in plants and their preparations
EP2275562B1 (de) 2005-09-16 2015-10-21 deVGen N.V. Verfahren auf Basis von transgenen Pflanzen zur Beämpfung von Schadinsekten unter Verwendung von RNAi
EP2269444A3 (de) 2005-09-16 2012-04-04 deVGen N.V. DSRNA als Bekämpfungsmittel gegen Insekten
EP1971687A2 (de) 2006-01-12 2008-09-24 Devgen NV Dsrna als mittel zur insektenbekämpfung
US8906876B2 (en) 2006-01-12 2014-12-09 Devgen Nv Methods for controlling pests using RNAi
EP1971688B1 (de) 2006-01-12 2012-03-14 Devgen NV Dsrna als mittel zur insektenbekämpfung
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
CA2815116A1 (en) 2010-10-27 2012-05-03 Devgen Nv Down-regulating gene expression in insect pests
WO2013071047A1 (en) * 2011-11-11 2013-05-16 Children's Medical Center Corporation Compositions and methods for in vitro transcription of rna
WO2020185831A1 (en) * 2019-03-12 2020-09-17 Varigen Biosciences Corporation Expression vector
WO2022011082A1 (en) * 2020-07-08 2022-01-13 Stellate Biotherapeutics, Inc. Compositions and methods for producing single stranded dna

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
US5017488A (en) * 1986-04-01 1991-05-21 University Of Medicine And Dentistry Of New Jersey Highly efficient dual T7/T3 promoter vector PJKF16 and dual SP6/T3 promoter vector PJFK15
US5955363A (en) * 1990-01-03 1999-09-21 Promega Corporation Vector for in vitro mutagenesis and use thereof
DE69119083T2 (de) 1990-09-27 1996-10-17 Invitrogen Corp Direkte klonierung von pcr amplifizierten nukleinsäuren
WO1993016170A1 (en) * 1992-02-06 1993-08-19 Gil Ho Choi Genetically engineered transmissible hypovirulence
EP0669399B1 (de) * 1994-02-28 2003-10-01 Shimadzu Corporation Oligonukleotide und Verfahren zum Nachweis von Bakterien
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
CA2222761A1 (en) * 1995-06-07 1996-12-19 Washington University Recombinant bacterial system with environmentally limited viability
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
FR2782325B1 (fr) * 1998-08-12 2002-05-24 Proteus Procede d'identification de sequences polynucleotidiques et/ou des proteines correspondantes a partir d'un echantillon d'acides nucleiques
GB9827152D0 (en) * 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
US6326193B1 (en) * 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs

Also Published As

Publication number Publication date
GB0112213D0 (en) 2001-07-11
DE60126760T2 (de) 2007-11-15
ES2356389T3 (es) 2011-04-07
GB0012233D0 (en) 2000-07-12
EP1285062B1 (de) 2007-02-21
US7358069B2 (en) 2008-04-15
ATE354652T1 (de) 2007-03-15
WO2001088121A1 (en) 2001-11-22
US7932062B2 (en) 2011-04-26
EP1285062A1 (de) 2003-02-26
JP2012228256A (ja) 2012-11-22
EP1775345B1 (de) 2010-12-22
EP1775345A2 (de) 2007-04-18
GB2365867B (en) 2002-08-14
GB2365867A (en) 2002-02-27
DE60126760D1 (de) 2007-04-05
EP1775345A3 (de) 2007-09-05
JP5153983B2 (ja) 2013-02-27
US20040166580A1 (en) 2004-08-26
ES2281420T3 (es) 2007-10-01
AU2001264166A1 (en) 2001-11-26
JP2004524804A (ja) 2004-08-19
US20080241894A1 (en) 2008-10-02
JP5645886B2 (ja) 2014-12-24
DE60143718D1 (de) 2011-02-03

Similar Documents

Publication Publication Date Title
ATE492638T1 (de) Vektorkonstruktionen
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
ATE557095T1 (de) Replikatives in vivo gen-targeting
ATE318895T1 (de) Humanes delta 5-desaturase-gen
AU2002331313A1 (en) Use of l-polynucleotides and derivatives thereof for in vivo imaging
NO20031860D0 (no) Kahalaolid F
AU2001269575A1 (en) Nucleic acid sequences and proteins involved in cellular senescence
BR0003766A (pt) Misturas de tensoativos compreendendo ácido graxo n-alquilpolihidroxiamidas e ácido graxo amidoalcoxilatos
AU144678S (en) Bottle
DK1339853T3 (da) Isolerede luciferaser og deres anvendelse
HUP0300727A2 (hu) Nukleinsav-konstrukciók, ezekkel transzformált vaszkuláris sejtek, ezeket a konstrukciókat hasznosító gyógyászati kompozíciók, és eljárások angiogenezis indukálásához
MY139010A (en) 6-azo-5, 5'-dihydroxy -7,7'-disulfo-2-2'-dinaphthylamine derivatives
GB0315160D0 (en) In vitro amplification of DNA
DE50214566D1 (de) Bioanalytische Messverfahren zur Bestimmung von Katalasen und Peroxidasen, deren Konjugaten, Substraten, Aktivatoren, und Inhibitoren
AU1248602A (en) Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids
ATE430758T1 (de) Lipid-aminoglykosid konjugate zur transfektion
FI20011542A (fi) Urosognaasigeenin monistuman käyttö
DE60117001D1 (de) Nectin-3 proteine
ITTO20011213A0 (it) Prodotto coadiuvante nella crescita fisiologica dei capelli.
UA51042A (uk) Ручний вантажний візок
ITRM20020365A1 (it) Purificazione, clonazione e caratterizzazione biochimica di xendou, l'attivita' endoribonucleolitica coinvolta nella biosintesi, splicing-in
ATE330671T1 (de) Verwendung von alkyl 3-(n- alkylacetamino)propionat derivaten als feuchthaltemittel
SE0100096D0 (sv) Tissue specific genes and their promotors - apoptosis
SE0100097D0 (sv) Tissue specific genes and their promotors - cell division
ZA200210029B (en) Compositions and methods for the modification of gene expression.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties